Search the Newsreel

Is CONMED’s (CNMD) Earnings Beat And Higher Sales Outlook Reframing Its Core Investment Story?

CONMED (CNMD) Lifts Sales Outlook, Is The Stock 24% Overvalued?

Conmed Corp (CNMD) Stock News Today

This page provides an overview of Conmed Corp (CNMD) stock information, including its current market price, market capitalization, and P/E ratio. It also indicates that more news and analysis regarding the company's stock, earnings, and analyst ratings will be available soon. The platform, TradingKey, …

Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

Conmed Corp (CNMD) has an earnings forecast score of 5.71, ranking 183 out of 200 in its industry, with an average analyst price target of $52.00. Analysts currently recommend a "Hold" rating for the stock. The company's expected revenue for the next quarter is …

CONMED Corporation (CNMD) Stock Forecasts

Argus has raised its target price for CONMED Corporation (CNMD) to $53.00. The medical equipment company, based in Utica, New York, specializes in sports medicine procedures and general surgeries. The current stock price for CNMD is $49.12.

CONMED Corporation $CNMD Shares Sold by Edgestream Partners L.P.

Edgestream Partners L.P. significantly reduced its stake in CONMED Corporation (NYSE:CNMD) during the first quarter, selling 87.4% of its shares. Despite this, CONMED reported strong quarterly earnings, surpassing analyst expectations for both EPS and revenue, and maintained its fiscal 2026 EPS guidance. Analyst sentiment …

CONMED Corp Q2 2026: Revenue $343.5M, EPS $0.77— 10-Q Summary

CONMED Corp reported its Q2 2026 financial results, with revenue reaching $343.5 million, remaining relatively flat year-over-year. The company saw an increase in net income to $23.1 million and diluted earnings per share to $0.77. Growth was primarily driven by orthopedic sales, despite the …

CONMED Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:CNMD) 2026-07-31

Conmed Corp : JP Morgan Raises Target Price t

This article reports that JP Morgan has increased its target price for Conmed Corp. The specific details of the new target price and the rationale behind the upgrade are not provided in the snippet.

CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands

CONMED Corporation (CNMD) reported strong second-quarter 2026 results, with adjusted EPS of $1.38 and revenues of $343.5 million, both exceeding Zacks Consensus Estimates. The company saw organic constant-currency revenue growth of 6% driven by its AirSeal, Buffalo Filter, and BioBrace platforms, and an adjusted …

CONMED (NYSE:CNMD) Given New $46.00 Price Target at Wells Fargo & Company

Wells Fargo & Company has raised its price target for CONMED (NYSE:CNMD) to $46.00 from $39.00 while maintaining an "equal weight" rating. This adjustment follows CONMED's strong Q2 2026 earnings, where the company surpassed consensus estimates for both EPS and revenue, and provided optimistic …

Conmed: Q2 Earnings Snapshot

This article provides a Q2 earnings snapshot for Conmed. No specific financial details or further information are available within the provided content.

CONMED (CNMD) Stock Rallies On Profit Strength While Debt Still Looms

CONMED (NYSE: CNMD) lifts Q2 profit, exits gastro line and cuts notes

CONMED Corporation reported increased net income and diluted EPS for Q2 2026, reaching $23.1 million and $0.77 respectively, despite largely flat net sales year-over-year. The company's gross margin expanded to 57.5%, boosted by an IEEPA tariff refund, though partially offset by inventory write-downs due …

CONMED updates 2026 adjusted EPS outlook to $4.48-$4.60 after Q2

CONMED Corporation reported strong second-quarter 2026 financial results, with sales of $343.5 million and adjusted diluted EPS of $1.38, exceeding expectations. The company updated its full-year 2026 financial guidance for adjusted diluted EPS to range from $4.48 to $4.60, reflecting its Q2 performance and …

CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance

CONMED Corporation reported its second quarter 2026 financial results, with sales of $343.5 million, a 0.3% year-over-year increase, and adjusted diluted EPS up 20.0% to $1.38. The company updated its full-year 2026 financial guidance, anticipating net sales between $1.358 billion and $1.373 billion, and …

CONMED earnings ahead as investors weigh strategic sale prospects By Investing.com

CONMED Corporation is expected to report second-quarter earnings, with analysts anticipating $1.11 per share on $337.5 million in revenue. The medical device maker is also exploring a potential sale, which Bloomberg reported in mid-July, causing shares to rise significantly. Investors will be closely watching …

Conmed (CNMD) Reports Q2 Earnings: What Key Metrics Have to Say

CONMED Q2 Earnings Call Highlights

CONMED ($CNMD) Releases Q2 2026 Earnings, Stock Rises

CONMED’s (NYSE:CNMD) Q2 CY2026: Beats On Revenue, Stock Soars

CONMED (NYSE:CNMD) Posts Quarterly Earnings Results, Beats Expectations By $0.28 EPS

Conmed (CNMD) Q2 Earnings and Revenues Top Estimates

CONMED (CNMD) Could Be 12% Overvalued Ahead Of Wednesday Earnings

CONMED Number of Employees 2026 | Employee Count & Headcount Data

CONMED Corp. (CNMD) has approximately 3,868 employees worldwide as of March 2026, marking a 0.2% decline from 2023. The company, headquartered in Largo, Florida, is actively hiring with 212 job postings in 2026, and its workforce is primarily concentrated in the United States. Employee …

Earnings To Watch: CONMED (CNMD) Reports Q2 Results Tomorrow

Conmed Corp (CNMD) Institutional Confidence

Conmed Corp (CNMD) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion has seen a quarter-over-quarter decrease of 16.04%, with HOTCHKIS & WILEY as the largest institutional holder, possessing 1.05% of outstanding …

Conmed Corp (CNMD) Cash Flow

This article provides a detailed historical cash flow statement for Conmed Corp (CNMD), covering quarterly and annual data for operating, investing, and financing activities. It also includes definitions and explanations of key cash flow terms like operating cash flow, investing cash flow, financing cash …

Conmed Corp (CNMD) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Conmed Corp (CNMD), listing major institutional holders and their respective proportions. It also presents a breakdown of shareholder types such as investment advisors and hedge funds, as well as institutional shareholding activity over several quarters. Additionally, the …

Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Conmed Corp (CNMD), categorizing its revenue by business segment and geographical region. For the reported period, General Surgery accounted for 58.20% of total revenue, while Orthopedic Surgery contributed 41.80%. Geographically, the United States was the largest …

CNMD|Conmed Corp|Price:43.500|Chg%:+0.820

This article provides a comprehensive stock analysis of Conmed Corp (CNMD), highlighting its stable fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. It notes strong institutional ownership, recent "Hold" ratings from analysts with a target price of $38.80, …

CNMD|Conmed Corp|Price:42.730|Chg%:+1.460

This article provides a detailed financial overview of Conmed Corp (CNMD), including its stock price, market capitalization, P/E ratio, and upcoming earnings date. It presents a comprehensive look at the company's financial indicators such as EPS, revenue, net profit, margins, and debt-to-assets ratio across …

Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts for Conmed Corp (CNMD), detailing specific dividend events, including record dates, payment dates, and ex-dividend dates from 2023 through 2025. It indicates that Conmed Corp has distributed a total of 96.37 million USD in dividends …